Two other proteins, retinol-binding protein (RBP4) and BTD, were detected at significantly lower levels for the MS/CIS patients versus controls in both cohorts; however, levels of these proteins were not correlated with levels of APOA1 and GC, which may be due to a relationship to the stage of the disease or to individual differences. This evidence concerns the gene BTD and in situ carcinoma.